UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.3.d.004 Effects of the 5-HT2 receptor antagonist, eplivanserin, and the mGluR2/3 agonist, LY404039, in mice models of hyperactivity

European neuropsychopharmacology, 2011, Vol.21, p.S508-S508

2011

Volltextzugriff (PDF)

P.2.024 Attenuation by paroxetine and D-cycloserine of the deficit in cognitive processes following acute stress: an animal model of PTSD

European neuropsychopharmacology, 2010, Vol.20, p.S48-S49

2010

Volltextzugriff (PDF)

P.3.d.007 Phencyclidine decreases tickled-induced 50-kHz calls in juvenile rats: a model for schizophrenia

European neuropsychopharmacology, 2010, Vol.20, p.S501-S501

2010

Volltextzugriff (PDF)

P.3.d.001 SSR103800, an inhibitor of the GlyT-1 reverses hyperactivity in glutamatergic but not dopaminergic models in mice

European neuropsychopharmacology, 2008, Vol.18, p.S448-S449

2008

Volltextzugriff (PDF)

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

The Journal of pharmacology and experimental therapeutics, 2003-07, Vol.306 (1), p.407-420

2003

Volltextzugriff (PDF)

P.3.d.009 Effects of SSR103800, a novel GlyT1 inhibitor, on the behavior of NMDA Nr1 hypomorphic mice, a model of schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S478-S479

2007

Volltextzugriff (PDF)

Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia?

Behavioural pharmacology, 2013-10, Vol.24 (7), p.543-551

2013

Volltextzugriff (PDF)

Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo

Atherosclerosis, 2018-08, Vol.275, p.e17-e17

2018

Volltextzugriff (PDF)

Preclinical profile of befloxatone, a new reversible MAO-A inhibitor

Journal of affective disorders, 1998-12, Vol.51 (3), p.287-303

1998

Volltextzugriff (PDF)

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile

The Journal of pharmacology and experimental therapeutics, 1996-04, Vol.277 (1), p.265

1996

Volltextzugriff (PDF)

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

Pharmacology, biochemistry and behavior, 2008-03, Vol.89 (1), p.36-45

2008

Volltextzugriff (PDF)

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Pharmacology, biochemistry and behavior, 2008-11, Vol.91 (1), p.47-58

2008

Volltextzugriff (PDF)

A38 SSR240600 AND SAREDUTANT, NK-1 AND NK-2 RECEPTOR ANTAGONISTS, RESPECTIVELY, INCREASE SOCIAL INTERACTION IN RATS, IN A MODEL SENSITIVE TO ANXIOLYTIC DRUGS

Behavioural pharmacology, 2005-09, Vol.16 (Supplement 1), p.S35

2005

Volltextzugriff (PDF)

A76A THE ??7nACh RECEPTOR AGONIST, SSR180711, DISPLAYS ANTIDEPRESSANT-LIKE EFFECTS IN RODENTS

Behavioural pharmacology, 2005-09, Vol.16 (Supplement 1), p.S47

2005

Volltextzugriff (PDF)

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties

The Journal of pharmacology and experimental therapeutics, 2002-08, Vol.302 (2), p.731

2002

Volltextzugriff (PDF)

Enhancement of long-term potentiation in the dentate gyrus two days after associative learning in the rat

Neuroscience research communications, 1990-01, Vol.6 (2), p.119-128

1990

Volltextzugriff (PDF)

GABA sub(A) and alpha -Amino-3-hydroxy-5-methylsoxazole-4-propionate Receptors Are Differentially Affected by Aging in the Rat Hippocampus

The Journal of biological chemistry, 2000-06, Vol.275 (26), p.19585-19593

2000

Volltextzugriff (PDF)

GABAA and α-Amino-3-hydroxy-5-methylsoxazole-4-propionate Receptors Are Differentially Affected by Aging in the Rat Hippocampus

The Journal of biological chemistry, 2000-06, Vol.275 (26), p.19585-19593

2000

Volltextzugriff (PDF)

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

The Journal of pharmacology and experimental therapeutics, 2003-07, Vol.306 (1), p.407

2003

Volltextzugriff (PDF)

Enhancement of excitability and inhibitory processes in hippocampal dentate gyrus by noradrenaline: A pharmacological study in awake, freely moving rats

Neuroscience letters, 1991-05, Vol.126 (1), p.1-5

1991

Volltextzugriff (PDF)

Preclinical profile of befloxatone, a new reversible MAO-A inhibitor: Special Issue: A Decade of Antidepressant Development

Journal of affective disorders, 1998, Vol.51 (3), p.287-303

1998

Volltextzugriff (PDF)

PHARMACOLOGICAL PROFILE OF BEFLOXATONE, A NEW REVERSIBLE MAO-A INHIBITOR

Clinical neuropharmacology, 1992, Vol.15, p.423

1992

Volltextzugriff (PDF)

Influence des inégalités socio-territoriales sur la mortalité en excès de patients atteints de SEP en France : une étude rétrospective observationnelle

Revue neurologique, 2024-04, Vol.180, p.S134-S135

2024

Volltextzugriff (PDF)

Diccionario de diabetes: Vocablos de la especialidad para el médico

2020

Volltextzugriff (PDF)

630 HIGH SERUM LEVELS OF THE INTERLEUKIN 33 RECEPTOR SOLUBLE ST2 AS A NEGATIVE PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2013-04, Vol.58, p.S257-S257

2013

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P.3.d.004 Effects of the 5-HT2 receptor antagonist, eplivanserin, and the mGluR2/3 agonist, LY404039, in mice models of hyperactivity

P.2.024 Attenuation by paroxetine and D-cycloserine of the deficit in cognitive processes following acute stress: an animal model of PTSD

P.3.d.007 Phencyclidine decreases tickled-induced 50-kHz calls in juvenile rats: a model for schizophrenia

P.3.d.001 SSR103800, an inhibitor of the GlyT-1 reverses hyperactivity in glutamatergic but not dopaminergic models in mice

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

P.3.d.009 Effects of SSR103800, a novel GlyT1 inhibitor, on the behavior of NMDA Nr1 hypomorphic mice, a model of schizophrenia

Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia?

Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo

Preclinical profile of befloxatone, a new reversible MAO-A inhibitor

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

A38 SSR240600 AND SAREDUTANT, NK-1 AND NK-2 RECEPTOR ANTAGONISTS, RESPECTIVELY, INCREASE SOCIAL INTERACTION IN RATS, IN A MODEL SENSITIVE TO ANXIOLYTIC DRUGS

A76A THE ??7nACh RECEPTOR AGONIST, SSR180711, DISPLAYS ANTIDEPRESSANT-LIKE EFFECTS IN RODENTS

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties

Enhancement of long-term potentiation in the dentate gyrus two days after associative learning in the rat

GABA sub(A) and alpha -Amino-3-hydroxy-5-methylsoxazole-4-propionate Receptors Are Differentially Affected by Aging in the Rat Hippocampus

GABAA and α-Amino-3-hydroxy-5-methylsoxazole-4-propionate Receptors Are Differentially Affected by Aging in the Rat Hippocampus

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

Enhancement of excitability and inhibitory processes in hippocampal dentate gyrus by noradrenaline: A pharmacological study in awake, freely moving rats

Preclinical profile of befloxatone, a new reversible MAO-A inhibitor: Special Issue: A Decade of Antidepressant Development

PHARMACOLOGICAL PROFILE OF BEFLOXATONE, A NEW REVERSIBLE MAO-A INHIBITOR

Influence des inégalités socio-territoriales sur la mortalité en excès de patients atteints de SEP en France : une étude rétrospective observationnelle

Diccionario de diabetes: Vocablos de la especialidad para el médico

630 HIGH SERUM LEVELS OF THE INTERLEUKIN 33 RECEPTOR SOLUBLE ST2 AS A NEGATIVE PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA

Suchergebnisse filtern